| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/29/2004 | EP1461437A2 Expression vectors and promoters for heterologous gene expression |
| 09/29/2004 | EP1461428A2 Hybrid antibodies |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461082A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/29/2004 | EP1461081A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461074A2 Agents for enhancing the immune response |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1322750A4 Proteolysis targeting chimeric pharmaceutical |
| 09/29/2004 | EP1137808B1 Methods for making recombinant cells |
| 09/29/2004 | EP1060185A4 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/29/2004 | EP1005486A4 Inducible regulatory system and use thereof |
| 09/29/2004 | EP0970119A4 Synaptic activation protein compositions and method |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0826006B1 Transepithelial transport of molecular species |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | EP0675903B1 Bone resorption assay |
| 09/29/2004 | CN1533440A Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/29/2004 | CN1533438A Method for producing proteins in plants |
| 09/29/2004 | CN1533437A DNA sequences for regulating transcription |
| 09/29/2004 | CN1533432A COmpositions and methods for high-level, large-scale production of recombinant proteins |
| 09/29/2004 | CN1532289A Method for preparing N-end acetylation modified thymosin alpha with recombined E. coli |
| 09/29/2004 | CN1532284A Novel antibiotic polypeptide and its preparing method |
| 09/29/2004 | CN1168831C Construction of recombinant human B lymphocyte stimulating factor expression vector, DNA immunopreparation of monoclonal antibody and use thereof |
| 09/29/2004 | CN1168829C Calcium free subtilisin mutants |
| 09/29/2004 | CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine |
| 09/29/2004 | CN1168500C Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/28/2004 | US6797812 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797809 Multiple fusion antigens for use in immunoassays for anti-HCV antibodies |
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797690 Anti-freeze polypeptides for improving the freezing tolerance of foodstuffs |
| 09/28/2004 | US6797515 Regulated autocrine growth of mammalian cells |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797495 Somatic cells with ablated PrP gene and methods of use |
| 09/28/2004 | US6797490 Nucleotide sequences coding polypeptide for use in biological pest control |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/28/2004 | US6797475 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 09/28/2004 | US6797467 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 09/28/2004 | US6797274 Compounds |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/28/2004 | CA2147838C The pct-65 serotonin receptor |
| 09/24/2004 | CA2517496A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/23/2004 | WO2004081569A1 N1,n12-diacetylspermine as tumor marker |
| 09/23/2004 | WO2004081515A2 Purification process for bacterial cytolysin |
| 09/23/2004 | WO2004081202A1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS |
| 09/23/2004 | WO2004081201A1 Improved protein secretion in eukaryotic cells |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081049A1 Monoclonal antibodies that recognise mucosal addressin cell adhesion molecule-1 (madcam-1), soluble madcam-1 and uses thereof |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081034A2 Altering metabolism in biological processes |
| 09/23/2004 | WO2004081033A2 Synthesis of proteins by cell-free protein expression |
| 09/23/2004 | WO2004081032A2 Novel litaf binding site peptides and methods of using the same |
| 09/23/2004 | WO2004081027A2 Neoplasm specific antibodies and uses thereof |
| 09/23/2004 | WO2004080579A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 09/23/2004 | WO2004080403A2 Influenza virus vaccine |
| 09/23/2004 | WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16 |
| 09/23/2004 | WO2004044555A3 Diagnosis of sepsis or sirs using biomarker profiles |
| 09/23/2004 | WO2004015391A3 Mass spectrometry-based identification of proteins |
| 09/23/2004 | WO2004010947A3 Humanized antibodies against human 4-1bb |
| 09/23/2004 | WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003096969A3 Novel lambda phage display system and the process |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/23/2004 | WO2003070880A3 Bacteria with reduced genome |
| 09/23/2004 | WO2003068735A3 Use of xylene monooxygenase for the oxidation of substituted polycyclic aromatic compounds |
| 09/23/2004 | WO2003046204A3 Humanized collagen antibodies and related methods |
| 09/23/2004 | WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040185562 Transforming cells with nucleotide sequences coding and expressing enzymatic polypeptides associated with biosynthesis of glucuronic, ascorbic and glucaric acids; bioreactors |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185535 for factor VII or factor VII-related polypeptides using a macroporous carrier |
| 09/23/2004 | US20040185534 for factor VII or factor VII-related polypeptides using a macroporous carrier |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185531 for use in biosensors/bioreactors; for drug screening; solid phase synthesis; genetic engineering |
| 09/23/2004 | US20040185528 Method for improved protein expression in bacteria by monitoring and modulating protein folding |
| 09/23/2004 | US20040185526 Preparing N-benzyloxycarbonyl- alpha -L-aspartyl-L-phenylalanine methyl ester (Z-APM) by high-conversion enzymatic coupling of N-benzyloxycarbonyl-L-aspartic acid (Z-Asp) and L-phenylalanine methyl ester (L-PM); artificial sweetners |
| 09/23/2004 | US20040185525 Process for producing peptide |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185436 chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases; kits |
| 09/23/2004 | US20040185147 Adding transglutaminase to vegetable protein extract to catalyze acyl transfer from glutamine to lysine in peptide and partially crosslink protein, precipitating with acid, removing enzyme, neutralizing, pasteurizing, drying to powder |
| 09/23/2004 | US20040185044 Use of human antibody which recognises apolipoprotein CIII; atherosclerosis or dyslipidaemia treatment; passive vaccination |
| 09/23/2004 | DE10309557A1 Ein Translokationsenzym als Selektionsmarker A Translokationsenzym as a selection marker |
| 09/23/2004 | DE10309555A1 New peptide chain release factor B, useful for improving recombinant protein production in bacteria, also a more active variant and related nucleic acids, vectors and cells, accelerates release of proteins from the ribosome |
| 09/23/2004 | CA2812817A1 Purification process |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518669A1 Purification process |
| 09/23/2004 | CA2518580A1 Improved protein secretion in eukaryotic cells |
| 09/23/2004 | CA2516919A1 Influenza virus vaccine |